🇺🇸 AMGN — Amgen Inc.

Healthcare Compra
← Volver

Precio actual

437,23 USD

Máx. histórico

447,03

10 días

Split 2:1 del 22/11/1999

Caída desde máximo

-2,19%

Rango 52 semanas

269,77 – 447,03

Variación hoy

-1,55%

Cierre anterior

444,12

Rango de hoy

435,01 – 441,66

Volumen hoy

1.656.089

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
31.500
PER ⓘ
27,17 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
389,69 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 3 días
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,27%
Fecha de pago Importe por participación
21/08/2026 2,5200 USD
15/05/2026 2,5200 USD
13/02/2026 2,5200 USD
21/11/2025 2,3800 USD
22/08/2025 2,3800 USD
16/05/2025 2,3800 USD
14/02/2025 2,3800 USD
18/11/2024 2,2500 USD
16/08/2024 2,2500 USD
16/05/2024 2,2500 USD
15/02/2024 2,2500 USD
16/11/2023 2,1300 USD
17/08/2023 2,1300 USD
17/05/2023 2,1300 USD
14/02/2023 2,1300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
22/11/1999 2:1
01/03/1999 2:1
16/08/1995 2:1
11/09/1991 3:1
13/08/1990 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
28/01/2000 61,44 61,44 59,38 59,69 -2,75% 3,36% 10.899.900
27/01/2000 65,00 65,06 59,13 61,38 -4,29% 9,13% 14.797.000
26/01/2000 67,88 68,88 64,06 64,13 -7,57% 7,09% 16.000.800
25/01/2000 70,75 70,81 66,00 69,38 +0,18% 6,80% 11.251.900
24/01/2000 75,88 76,50 69,13 69,25 -7,28% 9,72% 9.853.500
21/01/2000 73,38 75,00 72,00 74,69 +4,00% 4,09% 8.154.300
20/01/2000 74,38 74,50 69,63 71,81 -0,26% 6,55% 9.460.900
19/01/2000 70,00 72,94 69,88 72,00 +4,25% 4,38% 12.070.900
18/01/2000 70,00 70,13 68,25 69,06 +1,10% 2,68% 8.658.100
14/01/2000 68,88 70,00 67,38 68,31 +2,25% 3,81% 8.971.200
13/01/2000 64,75 67,75 63,81 66,81 +5,11% 6,08% 10.552.600
12/01/2000 67,63 67,75 62,56 63,56 -4,33% 7,67% 11.576.800
11/01/2000 72,06 72,38 64,13 66,44 -7,89% 11,45% 14.103.100
10/01/2000 69,50 72,69 69,50 72,13 +6,07% 4,59% 10.555.300
07/01/2000 62,75 68,50 62,63 68,00 +11,25% 9,36% 15.953.900
06/01/2000 60,75 61,94 60,25 61,13 +1,66% 2,78% 11.118.400
05/01/2000 59,19 60,69 58,25 60,13 +3,44% 4,12% 15.071.400
04/01/2000 62,00 64,13 57,69 58,13 -7,65% 10,38% 15.052.600
03/01/2000 70,00 70,00 62,88 62,94 +4,79% 10,18% 22.914.900
31/12/1999 65,38 65,50 59,88 60,06 -7,42% 8,60% 2.610.400
30/12/1999 63,75 66,44 63,56 64,88 +4,95% 4,51% 5.499.100
29/12/1999 58,75 62,00 57,50 61,81 +7,15% 7,66% 6.529.300
28/12/1999 55,06 58,25 54,88 57,69 +8,46% 6,13% 7.643.600
27/12/1999 54,94 55,00 51,13 53,19 -1,85% 7,05% 5.246.100
23/12/1999 54,00 54,81 52,75 54,19 +2,36% 3,82% 6.669.000
22/12/1999 50,67 53,06 50,25 52,94 +5,61% 5,55% 9.230.500
21/12/1999 49,00 50,44 48,63 50,13 +2,56% 3,70% 8.224.800
20/12/1999 45,63 49,63 45,13 48,88 +7,27% 9,86% 9.173.100
17/12/1999 45,75 46,38 44,75 45,56 +2,53% 3,55% 10.599.200
16/12/1999 45,50 45,63 43,50 44,44 -2,47% 4,67% 9.175.200